Investigating Non-invasive Brain Stimulation to Enhance Fluency in People Who Stutter
INSTEP
1 other identifier
interventional
43
1 country
1
Brief Summary
This study aims to test whether the application of transcranial direct current stimulation (tDCS) concurrent with fluency training results in improvements in speech fluency in adults with developmental stuttering, measured up to three months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedStudy Start
First participant enrolled
November 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedMay 18, 2022
May 1, 2022
2.5 years
October 26, 2017
May 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Stuttering Severity Instrument (SSI-4) Score
The Stuttering Severity Instrument (SSI-4) is a standardised measure of stuttering severity comprised of 3 sub-scores (frequency, duration and physical concomitants) which are summed to give a total score. We will use change from baseline in total score (i.e. baseline subtracted) on the Stuttering Severity Instrument version 4 measured post intervention. The maximum total score of the SSI-4 is 56, which corresponds to the highest stuttering severity. Therefore, larger negative change scores represent better outcomes (larger reductions in stuttering severity).
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
Secondary Outcomes (3)
Change in percentage of disfluent syllables produced during conversation
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
Change in percentage of disfluent syllables produced during reading
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
Change in Overall Assessment of the Speaker's Experience of Stuttering (OASES) score
6 weeks and 12 weeks after the end of the 5-day intervention
Other Outcomes (6)
Change in Premonitory Awareness in Stuttering Scale
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
Change in Beck Anxiety Inventory
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
Change in Subjective rating of stuttering severity
1 week, 6 weeks and 12 weeks after the end of the 5-day intervention
- +3 more other outcomes
Study Arms (2)
Active TDCS and Fluency Intervention
ACTIVE COMPARATORParticipants will receive 1-milliamp (mA) tDCS with the anode (5 x 7 cm) placed over the left frontal cortex and the cathode (5 x 7 cm) placed symmetrically over the right frontal cortex. tDCS will be delivered using a direct current (DC) stimulator in 'study-mode' for 20 minutes a day for five consecutive days. he stimulation will be applied for the first half of a 40-minute speech fluency training paradigm, using metronome-timed speech.
Sham TDCS and Fluency Intervention
SHAM COMPARATORParticipants will receive sham stimulation with the anode and cathode electrodes placed over the left and right frontal cortex as in the active arm. Sham stimulation will be delivered using a DC-stimulator in 'study-mode' for 20 minutes a day for five consecutive days. For sham stimulation, the current is ramped up over 15 seconds, maintained for 15 seconds at 1 mA and ramped down over 15 seconds at the start of stimulation and is then followed by brief (3ms) pulses every 55 seconds for the remainder of the 20-minute stimulation session. he stimulation will be applied for the first half of a 40-minute speech fluency training paradigm, using metronome-timed speech.
Interventions
Reading, narrative, and conversational speech tasks will be completed on each of the five intervention days. Metronome- timed speech will be practiced during these tasks, at near-normal (comfortable) speech rate for each participant. Each intervention session will be 40 minutes in duration.
1-mA tDCS with the anode (5 x 7 cm) placed over the left frontal cortex and the cathode (5 x 7 cm) placed symmetrically over the right frontal cortex. tDCS will be delivered using a direct current (DC) stimulator in 'study-mode' for 20 minutes. The current is ramped up to 1 mA over the first 15 seconds of stimulation and maintained at this level for remainder of the 20-minute stimulation session.
Sham stimulation will be delivered using a DC-stimulator in 'study-mode' for 20 minutes. Participants will receive sham stimulation with the anode and cathode electrodes placed over the left and right frontal cortex as in the active arm. For sham stimulation, the current is ramped up over 15 seconds, maintained for 15 seconds at 1 mA and ramped down over 15 seconds at the start of stimulation and is then followed by brief (3ms) pulses every 55 seconds for the remainder of the 20-minute stimulation session.
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Diagnosed with developmental stuttering of mild-moderate or greater severity
- Native speaker of English
- Normal or corrected-to-normal vision
- Normal hearing
You may not qualify if:
- Speech, language or communication disorder other than developmental stuttering.
- Contraindication to brain stimulation (tDCS or TMS)
- Contraindication to MRI
- History of drug abuse
- History of a neurological or psychiatric illness
- Any previous neurosurgical procedures
- Taking prescription or over-the-counter medication that may affect brain function (for example, anti-depressants)
- Family history of epilepsy (first degree relative)
- Severe claustrophobia (as they may be unable to tolerate scanner)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Experimental Psychology, University of Oxford
Oxford, OX2 6BW, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kate E Watkins, PhD
University of Oxford
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- A researcher from another research group who is not involved in any aspect of the trial will perform the randomisation of participants into the sham and tDCS study arms using a minimisation procedure within "randPack" package in R (Carey and Gentleman, 2016). Allocation concealment will be achieved by assigning a unique 5-digit code per participant (containing no identifying information regarding trial arm). This will be emailed to the researcher. The code is used to deliver stimulation via study mode on the stimulator (http://www.neurocaregroup.com/dc\ stimulator\ plus.html). The participants and the researchers who will deliver the intervention, assess the outcomes, and analyse the data will be masked to trial arm.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2017
First Posted
November 8, 2017
Study Start
November 15, 2017
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
May 18, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share